Keywords: european, commission, clears, sanofi, msd/merck, co, zostavax

European Commission clears Sanofi MSD/Merck & Co's Zostavax in European Union

Article | 05 June 2006

Print This

The European Commission has granted a marketing authorization for Zostavax, an injection indicated for prevention of herpes zoster and herpes ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in